China Medical & HealthCare Group Limited（COLRF）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · COLRF · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2024-12	2023-12	2022-12	2021-12	2020-12
Revenue
Revenue	$1.63B	$1.57B	$1.44B	$1.48B	$1.21B
Cost of Revenue	$1.30B	$1.28B	$1.28B	$1.30B	$1.09B
Gross Profit	$0.32B	$0.29B	$0.16B	$0.18B	$0.12B
Gross Margin %(computed)	19.95%	18.24%	11.25%	11.92%	10.28%
Operating Expenses
R&D Expenses	$0.00B	$0.00B	$0.00B	$0.00B	$0.00B
G&A Expenses	$0.22B	$0.23B	$0.26B	$0.22B	$0.22B
Total Operating Expenses	$0.24B	$0.20B	$0.20B	$0.20B	$0.14B
Operating Income	$0.09B	$0.08B	($0.04B)	($0.02B)	($0.01B)
Operating Margin %(computed)	5.29%	5.30%	-2.73%	-1.43%	-1.07%
Interest Income	$0.03B	$0.02B	$0.00B	$0.00B	$0.00B
Interest Expense	$0.03B	$0.05B	$0.06B	$0.06B	$0.05B
Income Before Tax	$0.06B	$0.04B	($0.12B)	($0.11B)	($0.10B)
Income Tax Expense	$0.02B	$0.01B	$0.00B	$0.02B	$0.01B
Net Income	$0.03B	$0.01B	($0.12B)	($0.14B)	($0.11B)
Net Margin %(computed)	1.77%	0.72%	-8.59%	-9.30%	-9.21%
Per Share & EBITDA
EPS (Basic)	$0.03	$0.01	$-0.17	$-0.19	$-0.15
Wtd Avg Shares	1.09B	0.92B	0.73B	0.73B	0.73B
EBITDA	$0.18B	$0.17B	$0.05B	$0.05B	$0.07B
EBITDA Margin %(computed)	11.27%	11.14%	3.23%	3.54%	5.75%